Page 145 - Evelop News Today

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced that the company has entered into an exclusive partnership with Aptar Pharma, a global leader

THB30bn on capital expenditures to develop 5G leadership, improve 4G quality, and invest in digital and enterprise service platforms. Attachments Original document ... | October 26, 2021

BEIJING (dpa-AFX) - ReneSola Ltd (SOL), a solar project developer and operator, announced Monday the signing of a strategic partnership agreement with Italy's Terra Aurea Gela S.r.l to co-develop

Glocal Teen Hero is promoted by CYDA in India.

Equinor plans to develop capacity to store 15-30 million tonnes CO2 per year

LSP and Bpifrance, through its InnoBio 2 Fund, co-led international investor syndicate Egle Therapeutics SAS (Egle), an emerging biotechnology company focused on developing First-In-Class immunotherapies

MOSCOW, Oct. 21, 2021 /PRNewswire/ -- The technology of tenfold extension of service life of a single-photon detector for the Earth-orbit quantum communication channel has been developed by

TOKYO, Oct 21, 2021 - (JCN Newswire) - Tokai University, Toyohashi University of Technology, Chubu University, and DENSO Corporation have been developing testing equipment to detect SARS-CoV-2 with support

Edmonton, Alberta--(Newsfile Corp. - October 21, 2021) - TrustBIX Inc. (TSXV: TBIX) (OTCQB: TBIXF) ("TrustBIX" or the "Company") is pleased to announce that it signed an agreement on October 1, 2021,

RIYADH, Saudi Arabia, Oct. 21, 2021 /PRNewswire/ -- Dar Al Arkan, the leading real-estate company in Saudi Arabia, and Qetaifan Projects, a leading Qatari real estate development company owned